RecruitingPhase 4NCT05947760
Magnesium as an Adjuvant Agent for Postoperative Pain
Magnesium as an Adjuvant Agent for Postoperative Pain Control Following Periacetabular Osteotomy
Sponsor
University Hospitals Cleveland Medical Center
Enrollment
64 participants
Start Date
Mar 10, 2025
Study Type
INTERVENTIONAL
Conditions
Summary
Participants are being asked to participate in this research study because they have elected to undergo periacetabular osteotomy (PAO). This research study is looking at if using IV magnesium during surgery can help to reduce pain after surgery.
Eligibility
Min Age: 14 YearsMax Age: 89 Years
Inclusion Criteria1
- Patients undergoing periacetabular osteotomy with or without adjuvant hip arthroscopy
Exclusion Criteria5
- illiterate or non-English speaking patients
- patients with 2nd or 3rd degree AV block
- patients with severe renal insufficiency
- patients with heart failure
- patients with bradycardia
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DRUGIV Magnesium Sulfate
Participants will receive IV Magnesium Sulfate intraoperatively.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05947760
Related Trials
The Effect of Zolpidem on Outcomes Following Lumbar Spine Fusion
NCT057461431 location
Opioid-Free Orthopaedics
NCT046593173 locations
Lumbar Steroid Use in Patients Undergoing Posterior Lumbar Decompression
NCT050582871 location
Opioid Sparing Effect of an ISP Nerve Block on Post-Op Pain Control in Posterior Cervical Spine Surgery
NCT065705771 location
Fascial Plane Blocks and Quality of Recovery in Cardiac Surgery
NCT075571081 location